Gliomatosis cerebri type II: two case reports
Journal of Medical Case Reports
|October 16, 2009
Summary
Gliomatosis cerebri Type II is a rare brain tumor. Molecular analysis revealed overexpression of angiogenesis genes in a patient with poor prognosis, suggesting therapeutic targets.
Area of Science:
- Neuro-oncology
- Molecular Genetics
- Cancer Biology
Background:
- Gliomatosis cerebri presents as Type I and Type II.
- Type II gliomatosis cerebri is characterized by diffuse infiltration of the brain.
- Understanding the molecular underpinnings of Type II gliomatosis cerebri is crucial for improving patient outcomes.
Purpose of the Study:
- To conduct a histological and genetic study of two gliomatosis cerebri Type II cases.
- To correlate molecular findings with therapy and prognosis in gliomatosis cerebri Type II.
- To investigate potential therapeutic targets for gliomatosis cerebri Type II.
Main Methods:
- Histological and genetic analysis of two gliomatosis cerebri Type II patients.
- Surgical treatment, radiotherapy, and chemotherapy administered to both patients.
- Molecular analysis focusing on angiogenesis, drug resistance, and DNA repair genes.
Main Results:
- One patient survived 24 months post-treatment, while the other succumbed to the disease.
- Overexpression of vascular cell adhesion molecule 1 (VCAM1) and vascular endothelial growth factor (VEGF) genes was observed in the patient with poor prognosis.
- High expression of drug resistance and metallothionein genes, along with unmethylated O6-methylguanine methyltransferase, was noted in the patient who did not respond to chemotherapy.
Conclusions:
- Angiogenesis-related gene overexpression (VCAM1, VEGF) may indicate poor prognosis in gliomatosis cerebri Type II.
- Specific gene expression patterns, including drug resistance and metallothioneins, alongside O6-methylguanine methyltransferase status, can predict chemotherapy response.
- These molecular findings offer insights into therapeutic strategies for gliomatosis cerebri Type II.
Related Concept Videos
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:11Cerebrum: Anatomical Overview II
Each cerebral hemisphere can be divided into three main regions. The outermost region, the cerebral cortex, is a thin layer (2 to 4 millimeters thick) made up of gray matter, consisting of neuron cell bodies, dendrites, glial cells, and blood vessels. The middle region, or white matter, is primarily composed of myelinated nerve fibers organized into three types of large tracts: association fibers, commissures, and projection fibers. Association fibers connect different areas within the same...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...